Literature DB >> 26888475

Re-Examining Risk of Repeated HLA Mismatch in Kidney Transplantation.

Kathryn J Tinckam1, Caren Rose2, Sundaram Hariharan3, John Gill4.   

Abstract

Kidney retransplantation is a risk factor for decreased allograft survival. Repeated mismatched HLA antigens between first and second transplant may be a stimulus for immune memory responses and increased risk of alloimmune damage to the second allograft. Historical data identified a role of repeated HLA mismatches in allograft loss. However, evolution of HLA testing methods and a modern transplant era necessitate re-examination of this role to more accurately risk-stratify recipients. We conducted a contemporary registry analysis of data from 13,789 patients who received a second kidney transplant from 1995 to 2011, of which 3868 had one or more repeated mismatches. Multivariable Cox proportional hazards modeling revealed no effect of repeated mismatches on all-cause or death-censored graft loss. Analysis of predefined subgroups, however, showed that any class 2 repeated mismatch increased the hazard of death-censored graft loss, particularly in patients with detectable panel-reactive antibody before second transplant (hazard ratio [HR], 1.15; 95% confidence interval [95% CI], 1.02 to 1.29). Furthermore, in those who had nephrectomy of the first allograft, class 2 repeated mismatches specifically associated with all-cause (HR, 1.30; 95% CI, 1.07 to 1.58) and death-censored graft loss (HR, 1.41; 95% CI, 1.12 to 1.78). These updated data redefine the effect of repeated mismatches in retransplantation and challenge the paradigm that repeated mismatches in isolation confer increased immunologic risk. We also defined clear recipient categories for which repeated mismatches may be of greater concern in a contemporary cohort. Additional studies are needed to determine appropriate interventions for these recipients.
Copyright © 2016 by the American Society of Nephrology.

Entities:  

Keywords:  chronic allograft failure; kidney transplantation; renal transplantation; transplant nephrectomy; transplant outcomes; transplantation

Mesh:

Substances:

Year:  2016        PMID: 26888475      PMCID: PMC5004649          DOI: 10.1681/ASN.2015060626

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  36 in total

1.  Renal retransplantation in patients with HLA-antibodies.

Authors:  L Mjörnstedt; J Konar; G Nyberg; M Olausson; L Sandberg; I Karlberg
Journal:  Transpl Int       Date:  1992       Impact factor: 3.782

2.  HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP.

Authors:  Rene J Duquesnoy; Medhat Askar
Journal:  Hum Immunol       Date:  2006-10-30       Impact factor: 2.850

3.  Scoring total inflammation is superior to the current Banff inflammation score in predicting outcome and the degree of molecular disturbance in renal allografts.

Authors:  M Mengel; J Reeve; S Bunnag; G Einecke; G S Jhangri; B Sis; K Famulski; L Guembes-Hidalgo; P F Halloran
Journal:  Am J Transplant       Date:  2009-06-26       Impact factor: 8.086

4.  HLA-DR and -DQ eplet mismatches and transplant glomerulopathy: a nested case-control study.

Authors:  R Sapir-Pichhadze; K Tinckam; K Quach; A G Logan; A Laupacis; R John; J Beyene; S J Kim
Journal:  Am J Transplant       Date:  2014-12-17       Impact factor: 8.086

5.  Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure.

Authors:  R B Mannon; A J Matas; J Grande; R Leduc; J Connett; B Kasiske; J M Cecka; R S Gaston; F Cosio; S Gourishankar; P F Halloran; L Hunsicker; D Rush
Journal:  Am J Transplant       Date:  2010-09       Impact factor: 8.086

6.  Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival?

Authors:  A C Farney; A J Matas; H J Noreen; N Reinsmoen; M Segall; W J Schmidt; K Gillingham; J S Najarian; D E Sutherland
Journal:  Clin Transplant       Date:  1996-04       Impact factor: 2.863

7.  Reducing de novo donor-specific antibody levels during acute rejection diminishes renal allograft loss.

Authors:  M J Everly; J J Everly; L J Arend; P Brailey; B Susskind; A Govil; A Rike; P Roy-Chaudhury; G Mogilishetty; R R Alloway; A Tevar; E S Woodle
Journal:  Am J Transplant       Date:  2009-03-16       Impact factor: 8.086

8.  Class II HLA epitope matching-A strategy to minimize de novo donor-specific antibody development and improve outcomes.

Authors:  C Wiebe; D Pochinco; T D Blydt-Hansen; J Ho; P E Birk; M Karpinski; A Goldberg; L J Storsley; I W Gibson; D N Rush; P W Nickerson
Journal:  Am J Transplant       Date:  2013-10-25       Impact factor: 8.086

9.  Renal transplantation and B-cell cross-matches with autoantibodies and alloantibodies.

Authors:  A Ting; P J Morris
Journal:  Lancet       Date:  1977-11-26       Impact factor: 79.321

10.  The IMGT/HLA database.

Authors:  James Robinson; Kavita Mistry; Hamish McWilliam; Rodrigo Lopez; Peter Parham; Steven G E Marsh
Journal:  Nucleic Acids Res       Date:  2010-11-11       Impact factor: 16.971

View more
  10 in total

1.  Access to Kidney Transplantation after a Failed First Kidney Transplant and Associations with Patient and Allograft Survival: An Analysis of National Data to Inform Allocation Policy.

Authors:  Stephanie Clark; Matthew Kadatz; Jagbir Gill; John S Gill
Journal:  Clin J Am Soc Nephrol       Date:  2019-07-23       Impact factor: 8.237

Review 2.  Antibody-mediated rejection: prevention, monitoring and treatment dilemmas.

Authors:  Sonia Rodriguez-Ramirez; Ayman Al Jurdi; Ana Konvalinka; Leonardo V Riella
Journal:  Curr Opin Organ Transplant       Date:  2022-08-11       Impact factor: 2.269

3.  Kidney Retransplantation after Graft Failure: Variables Influencing Long-Term Survival.

Authors:  Jonas Ehrsam; Fabian Rössler; Karoline Horisberger; Kerstin Hübel; Jakob Nilsson; Olivier de Rougemont
Journal:  J Transplant       Date:  2022-06-22

Review 4.  HLA Mismatching Strategies for Solid Organ Transplantation - A Balancing Act.

Authors:  Andrea A Zachary; Mary S Leffell
Journal:  Front Immunol       Date:  2016-12-07       Impact factor: 7.561

5.  Benchmarking the HLA typing performance of Polysolver and Optitype in 50 Danish parental trios.

Authors:  Maria Luisa Matey-Hernandez; Søren Brunak; Jose M G Izarzugaza
Journal:  BMC Bioinformatics       Date:  2018-06-25       Impact factor: 3.169

Review 6.  Strategies to Overcome HLA Sensitization and Improve Access to Retransplantation after Kidney Graft Loss.

Authors:  Rita Leal; Clara Pardinhas; António Martinho; Helena Oliveira Sá; Arnaldo Figueiredo; Rui Alves
Journal:  J Clin Med       Date:  2022-09-28       Impact factor: 4.964

7.  Outcomes at 3 years posttransplant in imlifidase-desensitized kidney transplant patients.

Authors:  Christian Kjellman; Angela Q Maldonado; Kristoffer Sjöholm; Bonnie E Lonze; Robert A Montgomery; Anna Runström; Tomas Lorant; Niraj M Desai; Christophe Legendre; Torbjörn Lundgren; Bengt von Zur Mühlen; Ashley A Vo; Håkan Olsson; Stanley C Jordan
Journal:  Am J Transplant       Date:  2021-07-19       Impact factor: 9.369

Review 8.  Management of chronic renal allograft dysfunction and when to re-transplant.

Authors:  Richard J Baker; Stephen D Marks
Journal:  Pediatr Nephrol       Date:  2018-07-23       Impact factor: 3.714

Review 9.  Does HLA matching matter in the modern era of renal transplantation?

Authors:  Jon Jin Kim; Susan V Fuggle; Stephen D Marks
Journal:  Pediatr Nephrol       Date:  2019-12-09       Impact factor: 3.714

10.  Humanized Mouse Model as a Novel Approach in the Assessment of Human Allogeneic Responses in Organ Transplantation.

Authors:  Ashwin Ajith; Laura L Mulloy; Md Abu Musa; Valia Bravo-Egana; Daniel David Horuzsko; Imran Gani; Anatolij Horuzsko
Journal:  Front Immunol       Date:  2021-06-11       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.